Evidence-backed pain relief Curable has a proven, science-backed approach to non-pharmacological chronic pain management with independent clinical research and real-world data, presenting a compelling case for partnerships with healthcare providers, payers, and employer health programs seeking scalable digital therapeutics.

Global reach with clinician ties With over a million users worldwide and thousands of clinicians, researchers, and organizations leveraging the program, there are strong sales opportunities in clinical networks, academic collaborations, and enterprise health initiatives that require scalable pain management tools.

High sales potential Revenue appears modest but growing within the $1M–$10M range, suggesting subsequent upsell opportunities through enterprise licensing, white-labeling, or integration with EHRs and patient engagement platforms to expand market adoption.

Alignment with mental health trends Curable targets the intersection of chronic pain and nervous system regulation, aligning with rising demand for digital therapeutics addressing stress, anxiety, and pain; potential collaborations with behavioral health providers and wellness programs.

Technology and integration ready The digital platform nature implies opportunities for API integrations, data interoperability with health IT ecosystems, and partnerships with digital health startups and EHR vendors seeking evidence-based non-drug solutions to pain management.